Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland.
作者信息
Perez-Saez Javier, Lauer Stephen A, Kaiser Laurent, Regard Simon, Delaporte Elisabeth, Guessous Idris, Stringhini Silvia, Azman Andrew S
机构信息
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, MD, USA; Institute of Global Health, University of Geneva, Switzerland.
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, MD, USA.
出版信息
Lancet Infect Dis. 2021 Apr;21(4):e69-e70. doi: 10.1016/S1473-3099(20)30584-3. Epub 2020 Jul 14.
Abstract
摘要
相似文献
1
Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland.瑞士日内瓦基于血清学的新型冠状病毒2感染致死风险评估
Lancet Infect Dis. 2021 Apr;21(4):e69-e70. doi: 10.1016/S1473-3099(20)30584-3. Epub 2020 Jul 14.
2
Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: a model-based analysis.在 2020 年春季大流行期间估计 SARS-CoV-2 在纽约市的感染病死率：基于模型的分析。
Lancet Infect Dis. 2021 Feb;21(2):203-212. doi: 10.1016/S1473-3099(20)30769-6. Epub 2020 Oct 19.
3
Estimating COVID-19 mortality in Italy early in the COVID-19 pandemic.估算 COVID-19 大流行早期意大利的 COVID-19 死亡率。
Nat Commun. 2021 May 12;12(1):2729. doi: 10.1038/s41467-021-22944-0.
4
Specchio-COVID19 cohort study: a longitudinal follow-up of SARS-CoV-2 serosurvey participants in the canton of Geneva, Switzerland.镜-COVID19 队列研究：瑞士日内瓦州 SARS-CoV-2 血清学调查参与者的纵向随访。
BMJ Open. 2022 Jan 31;12(1):e055515. doi: 10.1136/bmjopen-2021-055515.
5
Viral load of SARS-CoV-2 across patients and compared to other respiratory viruses.新型冠状病毒肺炎患者的严重急性呼吸综合征冠状病毒2病毒载量，并与其他呼吸道病毒进行比较。
Microbes Infect. 2020 Nov-Dec;22(10):617-621. doi: 10.1016/j.micinf.2020.08.004. Epub 2020 Sep 7.
6
Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19).人重组 C1 酯酶抑制剂（康奈司他）预防 COVID-19 住院患者严重 SARS-CoV-2 感染的研究方案：一项随机、平行分组、开放标签、多中心试验的结构摘要（PROTECT-COVID-19）。
Trials. 2021 Jan 4;22(1):1. doi: 10.1186/s13063-020-04976-x.
7
A scaling approach to estimate the age-dependent COVID-19 infection fatality ratio from incomplete data.一种从不完整数据估算年龄依赖性新冠病毒感染致死率的缩放方法。
PLoS One. 2021 Feb 17;16(2):e0246831. doi: 10.1371/journal.pone.0246831. eCollection 2021.
8
A first analysis of excess mortality in Switzerland in 2020.瑞士 2020 年超额死亡率的初步分析。
PLoS One. 2021 Jun 17;16(6):e0253505. doi: 10.1371/journal.pone.0253505. eCollection 2021.
9
Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19.SARS-CoV-2 感染和 COVID-19 康复过程中抗 SARS-CoV-2 抗体的动态变化。
Nat Commun. 2020 Nov 27;11(1):6044. doi: 10.1038/s41467-020-19943-y.
10
Delay-adjusted age- and sex-specific case fatality rates for COVID-19 in South Korea: Evolution in the estimated risk of mortality throughout the epidemic.韩国调整年龄和性别后 COVID-19 的病死率：整个疫情期间死亡率估计风险的演变。
Int J Infect Dis. 2020 Dec;101:306-311. doi: 10.1016/j.ijid.2020.09.1478. Epub 2020 Oct 2.
引用本文的文献
1
Predicting SARS-CoV-2-specific CD4 and CD8 T-cell responses elicited by inactivated vaccines in healthy adults using machine learning models.使用机器学习模型预测灭活疫苗在健康成年人中引发的SARS-CoV-2特异性CD4和CD8 T细胞反应。
Clin Exp Med. 2025 Jul 8;25(1):236. doi: 10.1007/s10238-025-01772-2.
2
Improving case fatality ratio estimates in ongoing pandemics through case-to-death time distribution analysis.通过病例至死亡时间分布分析改进正在流行疾病的病死率估计
Sci Rep. 2025 Feb 13;15(1):5402. doi: 10.1038/s41598-025-89441-y.
3
The real-time infection hospitalisation and fatality risk across the COVID-19 pandemic in England.英格兰 COVID-19 大流行期间实时感染住院和病死率。
Nat Commun. 2024 May 31;15(1):4633. doi: 10.1038/s41467-024-47199-3.
4
Bayesian workflow for time-varying transmission in stratified compartmental infectious disease transmission models.分层房室传染病传播模型中时变传播的贝叶斯工作流程。
PLoS Comput Biol. 2024 Apr 29;20(4):e1011575. doi: 10.1371/journal.pcbi.1011575. eCollection 2024 Apr.
5
Estimates of early outbreak-specific SARS-CoV-2 epidemiological parameters from genomic data.从基因组数据估计早期爆发特异性 SARS-CoV-2 流行病学参数。
Proc Natl Acad Sci U S A. 2024 Jan 9;121(2):e2308125121. doi: 10.1073/pnas.2308125121. Epub 2024 Jan 4.
6
Psychological impact of COVID-19 and determinants among Spanish university students.COVID-19 对西班牙大学生的心理影响及其决定因素。
Front Public Health. 2023 Oct 18;11:1252849. doi: 10.3389/fpubh.2023.1252849. eCollection 2023.
7
Analysis of the prevalence of anti-SARS-CoV-2 antibodies in groups of medical and non-medical professions.分析医疗和非医疗职业群体中抗 SARS-CoV-2 抗体的流行情况。
Int J Occup Med Environ Health. 2023 Nov 27;36(5):643-655. doi: 10.13075/ijomeh.1896.02162. Epub 2023 Sep 27.
8
Unique SARS-CoV-2 Variants, Tourism Metrics, and B.1.2 Emergence in Early COVID-19 Pandemic: A Correlation Analysis in South Dakota.南达科他州早期新冠大流行期间 SARS-CoV-2 独特变体、旅游指标与 B.1.2 出现：相关性分析
Int J Environ Res Public Health. 2023 Sep 13;20(18):6748. doi: 10.3390/ijerph20186748.
9
Age-specific severity of severe acute respiratory syndrome coronavirus 2 in February 2020 to June 2021 in the Netherlands.2020 年 2 月至 2021 年 6 月期间荷兰不同年龄段严重急性呼吸综合征冠状病毒 2 型的严重程度。
Influenza Other Respir Viruses. 2023 Aug 22;17(8):e13174. doi: 10.1111/irv.13174. eCollection 2023 Aug.
10
Quantification of early nonpharmaceutical interventions aimed at slowing transmission of Coronavirus Disease 2019 in the Navajo Nation and surrounding states (Arizona, Colorado, New Mexico, and Utah).对旨在减缓2019冠状病毒病在纳瓦霍族及周边各州（亚利桑那州、科罗拉多州、新墨西哥州和犹他州）传播的早期非药物干预措施的量化。
PLOS Glob Public Health. 2023 Jun 21;3(6):e0001490. doi: 10.1371/journal.pgph.0001490. eCollection 2023.
本文引用的文献
1
A systematic review and meta-analysis of published research data on COVID-19 infection fatality rates.对已发表的关于 COVID-19 感染病死率的研究数据的系统回顾和荟萃分析。
Int J Infect Dis. 2020 Dec;101:138-148. doi: 10.1016/j.ijid.2020.09.1464. Epub 2020 Sep 29.
2
Are Seroprevalence Estimates for Severe Acute Respiratory Syndrome Coronavirus 2 Biased?血清阳性率估计对严重急性呼吸综合征冠状病毒 2 有偏差吗？
J Infect Dis. 2020 Nov 9;222(11):1772-1775. doi: 10.1093/infdis/jiaa523.
3
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study.瑞士日内瓦抗 SARS-CoV-2 IgG 抗体的血清流行率（SEROCoV-POP）：一项基于人群的研究。
Lancet. 2020 Aug 1;396(10247):313-319. doi: 10.1016/S0140-6736(20)31304-0. Epub 2020 Jun 11.
4
Estimating the infection and case fatality ratio for coronavirus disease (COVID-19) using age-adjusted data from the outbreak on the Diamond Princess cruise ship, February 2020.利用 2020 年 2 月钻石公主号游轮上疫情的年龄调整后数据估计冠状病毒病（COVID-19）的感染和病死率。
Euro Surveill. 2020 Mar;25(12). doi: 10.2807/1560-7917.ES.2020.25.12.2000256.
5
Early epidemiological assessment of the virulence of emerging infectious diseases: a case study of an influenza pandemic.新兴传染病毒力的早期流行病学评估：以流感大流行为例。
PLoS One. 2009 Aug 31;4(8):e6852. doi: 10.1371/journal.pone.0006852.
Zotero 插件